Back to top
more

ABM Industries (ABM)

(Delayed Data from NYSE)

$50.27 USD

50.27
1,046,090

-0.83 (-1.62%)

Updated Sep 24, 2024 04:00 PM ET

After-Market: $50.27 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (3 out of 252)

Industry: Building Products - Maintenance Service

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

ITGR Shares May Gain on the Completion of Irish Facility Expansions

by Zacks Equity Research

Integer Holdings announces the completion of its Irish facility expansions in Galway and New Ross to support growth.

Stryker Shares May Gain on the Completion of the Acquisition of NICO

by Zacks Equity Research

SYK completes the acquisition of NICO to strengthen its portfolio of solutions for tumor resection and the treatment of ICH.

SNN Stock Rises on the Completion of First Case With CATALYSTEM System

by Zacks Equity Research

Smith & Nephew announces the completion of the first case using the CATALYSTEM Primary Hip System.

Here's Why Hold Strategy is Apt for ABM Industries Stock Now

by Zacks Equity Research

ABM has consistently demonstrated its commitment to rewarding shareholders through dividends and share buybacks.

Here's Why You Should Retain McKesson Stock in Your Portfolio Now

by Zacks Equity Research

MCK's strategic collaborations and strength in Biologics raise optimism about the stock.

GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool

by Zacks Equity Research

GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.

CAH Stock May Gain Following the Distribution Agreement With Telix

by Zacks Equity Research

Cardinal Health and Telix announce an agreement selecting the former as a commercial radiopharmaceutical distributor to supply finished unit doses of Telix's Zircaix.

Here's Why You Should Retain Accuray Stock in Your Portfolio Now

by Zacks Equity Research

ARAY's solid product demand and revenue growth raise optimism about the stock.

NSPR Stock Declines Despite PMA Application Submission for CGuard

by Zacks Equity Research

InspireMD announces the submission of the PMA application to the FDA for marketing approval of the CGuard Prime EPS.

CVRX Stock Gains on Unveiling of Barostim's Positive Study Data

by Zacks Equity Research

CVRx announces the publication of positive study data for its Barostim therapy.

Merit Medical Gains 26.4% Year to Date: What's Driving the Stock?

by Zacks Equity Research

MMSI's shares gain on the back of strength in its Cardiovascular segment and a robust product portfolio.

SNN Stock Declines Despite the Launch of Its Patient-Matched Guides

by Zacks Equity Research

Smith & Nephew announces the launch of its TOTAL ANKLE Patient-Matched Guides to plan and perform total ankle replacement procedures.

ELEVATE Benefits ABM's Organic Growth Despite Rising Expenses

by Zacks Equity Research

ABM Industries focuses on providing transparent and efficient offerings to its clients and improving its talent management system.

Avanos Medical Stock May Gain From Brand Partnership With NFL

by Zacks Equity Research

AVNS' GAME READY announces a paid partnership with NFL defensive end and San Francisco 49ers star, Nick Bosa.

Solventum Shares May Gain on the Launch of Its New V.A.C Therapy

by Zacks Equity Research

SOLV announces the launch of its V.A.C. Peel and Place Dressing for providing efficient and effective care in case of negative pressure wound therapy.

Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now

by Zacks Equity Research

PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.

ABM Industries Shares Barely Move After Reporting Q3 Earnings Beat

by Zacks Equity Research

ABM's technical solutions, aviation and education segments reported y/y revenue growth in third-quarter fiscal 2024.

iRhythm Stock Gains Following Favorable Zio Monitor Study Data

by Zacks Equity Research

IRTC announces initial findings demonstrating the superior real-world performance of the next-generation Zio LTCM Monitor at the HRX 2024 meeting.

Fresenius Medical Care Stock Rises on NxStage VersiHD Launch

by Zacks Equity Research

FMS introduces NxStage VersiHD with GuideMe Software to simplify home dialysis and grow its patient base in the United States.

iRhythm Stock May Gain on Its Latest Deal With BioIntelliSense

by Zacks Equity Research

IRTC announces an exclusive license agreement with BioIntelliSense to develop and commercialize certain patented technology assets within AMC.

DENTSPLY SIRONA Stock May Gain on the Launch of Primescan 2

by Zacks Equity Research

XRAY introduces its new-generation intraoral scanner, Primescan 2, to provide effective and efficient care and comfort to patients.

McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch Hill

by Zacks Equity Research

MCK announces the sale of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, aligning with its strategy to grow oncology and biopharma services.

Are Business Services Stocks Lagging ABM Industries (ABM) This Year?

by Zacks Equity Research

Here is how ABM Industries (ABM) and CRA International (CRAI) have performed compared to their sector so far this year.

Here's What Key Metrics Tell Us About ABM Industries (ABM) Q3 Earnings

by Zacks Equity Research

While the top- and bottom-line numbers for ABM Industries (ABM) give a sense of how the business performed in the quarter ended July 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

ABM Industries (ABM) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

ABM Industries (ABM) delivered earnings and revenue surprises of 10.59% and 2.75%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?